1.Continuous Sterile Compounding and Infusion Warming Methods for Children Requiring Medical Care by Community Pharmacists: A Case Report
Takashi DOUMEKI ; Yoshitaka HASEGAWA ; Hitoshi ITO ; Mitsuo KOBAYASHI ; Ryota TSUKIOKA ; Miya OISHI
An Official Journal of the Japan Primary Care Association 2025;48(1):30-33
2.Saikokeishikankyoto was Effective for the Patient who Suffered from Chills and General Fatigue After Taking a COVID-19 Vaccine : A case Report
Hidenori TANAKA ; Aki ITO ; Hitoshi SHIMA ; Hajime NAKAE
Kampo Medicine 2023;74(1):98-101
A 47-year-old woman with body temperature 35.6 ℃ took the 3rd COVID-19 vaccine shot at our clinic on Day 1. Since she felt chills and suffered from genital bleeding on Day 3, she visited our clinic to take a gynecological examination. Her temperature was 37.1 ℃ at that time. On Day 15, she suffered sustained symptoms of chills and general fatigue, and she went to another internal medicine clinic to take a medical care. However, her condition was unexplained and she was referred to a general hospital. On Day 16, she came to our clinic to confirm results of the gynecological examination. Her symptoms persisted even though the data showed no problems, so we prescribed her saikokeishikankyoto (SAKK) for only 3 days. On Day 19, SAKK dramatically improved her symptoms. On Day 37, her temperature was 36.2 ℃ without any symptoms.
3.Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2–3N0 Gastric Cancer: a Multi-institutional Dataset Analysis
Keizo FUJITA ; Mitsuro KANDA ; Seiji ITO ; Yoshinari MOCHIZUKI ; Hitoshi TERAMOTO ; Kiyoshi ISHIGURE ; Toshifumi MURAI ; Takahiro ASADA ; Akiharu ISHIYAMA ; Hidenobu MATSUSHITA ; Chie TANAKA ; Daisuke KOBAYASHI ; Michitaka FUJIWARA ; Kenta MUROTANI ; Yasuhiro KODERA
Journal of Gastric Cancer 2020;20(1):41-49
PURPOSE:
Patients with pathological stage T1N+ or T2–3N0 gastric cancer may experience disease recurrence following curative gastrectomy. However, the current Japanese Gastric Cancer Treatment Guidelines do not recommend postoperative adjuvant chemotherapy for such patients. This study aimed to identify the prognostic factors for patients with pT1N+ or pT2–3N0 gastric cancer using a multi-institutional dataset.
MATERIALS AND METHODS:
We retrospectively analyzed the data obtained from 401 patients with pT1N+ or pT2–3N0 gastric cancer who underwent curative gastrectomy at 9 institutions between 2010 and 2014.
RESULTS:
Of the 401 patients assessed, 24 (6.0%) experienced postoperative disease recurrence. Multivariate analysis revealed that age ≥70 years (hazard ratio [HR], 2.62; 95% confidence interval [CI], 1.09–7.23; P=0.030) and lymphatic and/or venous invasion (lymphovascular invasion (LVI): HR, 7.88; 95% CI, 1.66–140.9; P=0.005) were independent prognostic factors for poor recurrence-free survival. There was no significant association between LVI and the site of initial recurrence.
CONCLUSIONS
LVI is an indicator of poor prognosis in patients with pT1N+ or pT2–3N0 gastric cancer.
4.Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction?.
Yuya SATO ; Hitoshi KATAI ; Maiko ITO ; Masahiro YURA ; Sho OTSUKI ; Yukinori YAMAGATA ; Shinji MORITA
Journal of Gastric Cancer 2018;18(4):339-347
PURPOSE: To evaluate the status of number 3b lymph node (LN) station in patients with adenocarcinoma of the esophagogastric junction (AEG) and to investigate the optimal indications for radical proximal gastrectomy (PG) for AEG. MATERIALS AND METHODS: Data of 51 patients with clinically advanced Siewert types II and III AEG who underwent total gastrectomy (TG) between April 2010 and July 2017 were reviewed. The proportion of metastatic LNs at each LN station was examined. Number 3 LN station was separately classified into number 3a and number 3b. The risk factors for number 3b LN metastasis and the clinicopathological features of number 3b-positive AEG patients were investigated. RESULTS: The incidences of LN metastasis were the highest in number 1 (47.1%), followed by number 2 (23.5%), number 3a (39.2%), and number 7 (23.5%) LN stations. LN metastasis in number 3b LN station was detected in 4 patients (7.8%). A gastric invasion length of more than 40 mm was a significant risk factor for number 3b LN metastasis. All 4 patients with number 3b-positive AEG had advanced cancer with a gastric invasion length of more than 40 mm. The 5-year survival rate of patients with a gastric invasion length of more than 40 mm was 50.0%. CONCLUSIONS: Radical PG may be indicated for patients with AEG with gastric invasion length of less than 40 mm.
Adenocarcinoma*
;
Esophagogastric Junction*
;
Gastrectomy*
;
Humans
;
Incidence
;
Lymph Nodes
;
Neoplasm Metastasis
;
Risk Factors
;
Survival Rate
5.The Current Situation and Problems of Domestic Crude Drug Production
Denichiro YAMAOKA ; Takashi ITO ; Hiroshi ASAMA ; Yoshiro SAHASHI ; Kazuo MITANI ; Donghyo KANG ; Hiromichi YASUI ; Hitoshi WATANABE
Kampo Medicine 2017;68(3):270-280
The consumption and sales of Kampo products, as well as the crude drugs that make up the products, have been increasing recently. However, the Kampo industry has been exhibiting a long-term decline due to the rise in price of imported crude drugs and reduction in standard prices of crude drugs by the Japanese National Health Insurance scheme. As the production of crude drug in Japan has been decreasing for the past thirty years, efforts have been made to improve the situation. Although the production of Aizu Ginseng decreased from 153 metric tons to 8 metric tons in Fukushima, university research institutes have initiated research on expansion of the farm field for Ginseng and reduction in a cultivation term. In Nara, farmers, pharmaceutical and food manufacturers, and university research institutes, aiming to develop new products using Yamato Angelica root, organized a joint council and have been working together to establish integrated systems from cultivation to sales. The Ministry of Agriculture, Forestry and Fisheries, the Ministry of Health, Labour and Welfare, and Japan Kampo Medicines Manufacturers Association have held local meetings with farmers and pharmaceutical companies in different areas throughout Japan over the past three years from fiscal year 2013. In order to reduce national healthcare costs by Kampo medicine, it is necessary to upgrade the health care system where not only Kampo extract products but also medicinal plants as raw materials including decoctions can be used. Discussions on measures to cover the costs of domestic production of crude drugs should be required.
6.Non-Randomized Confirmatory Trial of Laparoscopy-Assisted Total Gastrectomy and Proximal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG1401.
Kozo KATAOKA ; Hitoshi KATAI ; Junki MIZUSAWA ; Hiroshi KATAYAMA ; Kenichi NAKAMURA ; Shinji MORITA ; Takaki YOSHIKAWA ; Seiji ITO ; Takahiro KINOSHITA ; Takeo FUKAGAWA ; Mitsuru SASAKO
Journal of Gastric Cancer 2016;16(2):93-97
Several prospective studies on laparoscopy-assisted distal gastrectomy for early gastric cancer have been initiated, but no prospective study evaluating laparoscopy-assisted total gastrectomy or laparoscopy-assisted proximal gastrectomy has been completed to date. A non-randomized confirmatory trial was commenced in April 2015 to evaluate the safety of laparoscopy-assisted total gastrectomy and laparoscopy-assisted proximal gastrectomy for clinical stage I gastric cancer. A total of 245 patients will be accrued from 42 Japanese institutions over 3 years. The primary endpoint is the proportion of patients with anastomotic leakage. The secondary endpoints are overall survival, relapse-free survival, proportion of patients with completed laparoscopy-assisted total gastrectomy or laparoscopy-assisted proximal gastrectomy, proportion of patients with conversion to open surgery, adverse events, and short-term clinical outcomes. The UMIN Clinical Trials Registry number is UMIN000017155.
Anastomotic Leak
;
Asian Continental Ancestry Group
;
Conversion to Open Surgery
;
Gastrectomy*
;
Humans
;
Japan*
;
Laparoscopy
;
Medical Oncology*
;
Non-Randomized Controlled Trials as Topic
;
Prospective Studies
;
Stomach Neoplasms*
7.The current education program in all medical schools in Japan
Nobuo Nara ; Hiroshi Ito ; Masaaki Ito ; Miyuki Ino ; Yutaka Imai ; Masaru Kawasaki ; Keijiro Saku ; Toshiya Suzuki ; Mitsuru Seishima ; Takuzo Hano ; Saburo Horiuchi ; Masayuki Matsushita ; Atsushi Miyamoto ; Rika Moriya ; Masao Yamada ; Hitoshi Yokoyama
Medical Education 2016;47(6):363-366
The education program in all medical schools in Japan has been studied and analyzed every 2 years since 1974 by the curriculum committee of the Association of Japan Medical Colleges. Based on the most recent analysis in 2015, the marked innovation of medical education, such as an integrated curriculum, active learning, and clinical clerkship, was recognized.
8.Central Nervous System Drug Evaluation Using Positron Emission Tomography.
Mizuho SEKINE ; Jun MAEDA ; Hitoshi SHIMADA ; Tsuyoshi NOGAMI ; Ryosuke ARAKAWA ; Harumasa TAKANO ; Makoto HIGUCHI ; Hiroshi ITO ; Yoshiro OKUBO ; Tetsuya SUHARA
Clinical Psychopharmacology and Neuroscience 2011;9(1):9-16
In conventional pharmacological research in the field of mental disorders, pharmacological effect and dose have been estimated by ethological approach and in vitro data of affinity to the site of action. In addition, the frequency of administration has been estimated from drug kinetics in blood. However, there is a problem regarding an objective index of drug effects in the living body. Furthermore, the possibility that the concentration of drug in blood does not necessarily reflect the drug kinetics in target organs has been pointed out. Positron emission tomography (PET) techniques have made progress for more than 20 years, and made it possible to measure the distribution and kinetics of small molecule components in living brain. In this article, we focused on rational drug dosing using receptor occupancy and proof-of-concept of drugs in the drug development process using PET.
Brain
;
Central Nervous System
;
Drug Evaluation
;
Electrons
;
Kinetics
;
Mental Disorders
;
Norepinephrine Plasma Membrane Transport Proteins
;
Positron-Emission Tomography
;
Receptors, Dopamine D2
;
Serotonin Plasma Membrane Transport Proteins
9.Comparative Clinical Evaluation of the Efficacy and Safety between the Original Drug and Generic Products (II)
Yukinaga Kishikawa ; Tomomi Iwasaki ; Megumi Ito ; Kazuki Ishikura ; Kaoko Ikeda ; Keigo Sato ; Yumiko Kon-no ; Tomomi Yagi ; Soh Katsuyama ; Masaaki Shindo ; Daichi Minakawa ; Tetsuo Togo ; Hitoshi Nakamura ; Michinao Mizugaki
Japanese Journal of Drug Informatics 2011;13(3):86-94
Objective: The purpose of this study is to compare the clinical efficacy between original drugs and generic products. Candidate drugs included two types of hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors, simvastatin and pravastatin, because of their importance at reducing the health expenditure for hyperlipidemia.
Design: We retrospectively evaluated the efficacy (total cholesterol, triglyceride, low-density lipoprotein and high-density lipoprotein levels), safety (biochemical parameters), and medication adherence based on patient data. We set the follow-up period at 6 months before and after substitution. Data were analyzed by paired-sample t-tests (statistical significance level of 0.05).
Methods: The subjects included in this study were ambulatory patients visiting Nakajima Hospital for dyslipidemia treatment. Selected patients included those taking both the original drug and the generic product; i.e., patients who had substituted the original drug Lipovas® for the generic product Simvastatin OHARA, or those who had substituted the original drug Mevalotin® for the generic drug Pravatin®.
Results: A total of 118 patients in the simvastatin study and 43 patients in the pravastatin study were candidates for the present study. We found that there were no significant differences before and after substitution. Even though there were differences in some of the biochemical parameters, the range remained within normal levels. With regard to medication adherence, we found no significant differences.
Conclusion: In this study, we found no significant differences before and after substituting medications with generic drugs. Additionally, we found no subjective symptom changes after substitution. To develop clinical information on generic products and to store such information, it is important that pharmaceutical products be used appropriately.
10.Relation of dampness to sick building syndrome in Japanese public apartment houses.
Yasuaki SAIJO ; Yoshihiko NAKAGI ; Toshihiro ITO ; Yoshihiko SUGIOKA ; Hitoshi ENDO ; Takahiko YOSHIDA
Environmental Health and Preventive Medicine 2009;14(1):26-35
OBJECTIVESThe effect of dampness on sick building syndrome (SBS) symptoms has not been fully investigated in Japan. The purpose of this study is to elucidate the possible effects of dampness on SBS symptoms among residents in Japanese public apartment houses.
METHODSA questionnaire was used to investigate the degree of dampness in public apartment houses in Asahikawa, Japan, and its effect on SBS symptoms, involving 480 residents in 64 buildings. Dampness indicators were as follows: condensation on the windowpanes, condensation on the walls and/or closets, visible mold in the bathrooms, visible mold on the walls, window frames, and/or closet, moldy odor, slow drying of the wet towels in bathrooms, water leakage, and bad drainage in bathrooms.
RESULTSAll dampness indicators except for visible mold in bathrooms had significantly higher odds ratios (ORs) for all or any SBS symptoms after adjustment. The dampness index, the number of positive dampness indicators, was significantly related to all SBS symptoms after adjustment.
CONCLUSIONSThere are serious problems relating to dampness in Japanese public housing, which affects the health of residents. There is a need to educate the residents about the relationship between dampness and SBS, and building problems should be rectified.


Result Analysis
Print
Save
E-mail